Cancer is the second-leading cause of death in the United States, according to a 2026 Cancer Research Institute report.

Two patients receive the same immunotherapy for the same cancer. In one, the tumor retreats and stays gone for years. In the ...

Researchers at The University of Texas MD Anderson Cancer Center have identified a previously unknown role for B cells, which ...

BME50 - A USC Viterbi bioengineer is building digital tumors, cell by cell, with a goal that could change how oncologists treat breast cancer: knowing in advance which patients immunotherapy will ...

The treatment can reprogram immune cells that have been corrupted by the cancer, strengthening the body’s ability to attack.

An experimental treatment may have just given a 3-year-old boy with advanced liver cancer a new lease on life. Doctors at the Baylor College of Medicine in Texas and others detailed the ...

A UK trial swapped standard chemotherapy for a short course of pembrolizumab, and none of the 32 patients has relapsed.

Patients with a specific form of bowel cancer who received a short course of immunotherapy before surgery, rather than ...

Avita Health System has expanded advanced cancer care in the region with Pluvicto radioligand therapy and bispecific antibody ...

The ‘Real Housewives of Beverly Hills’ alum shared the health reminder amid a frank look at the struggles of ongoing ...

The Parker Institute for Cancer Immunotherapy (PICI) today announced the appointment of Maria Olson as Chief Advancement ...